Paediatric Gastroenterology

Mar 29, 2024 | academic.oup.com | Paediatric Gastroenterology |Cliniques Universitaires Saint-Luc

Accepted manuscripts are PDF versions of the author’s final manuscript, as accepted for publication by the journal but prior to copyediting or typesetting. They can be cited using the author(s), article title, journal title, year of online publication, and DOI. They will be replaced by the final typeset articles, which may therefore contain changes. The DOI will remain the same throughout.

Feb 14, 2024 | fg.bmj.com | R Mark Beattie |Paediatric Gastroenterology

Significance and structure of clinical research in the UK: an introduction for gastroenterology and hepatology nursesResearch is an essentail part of a modern, effective health service and integral to the delivery of safe and effective high-quality clinical care. In the first of two articles in this issue, the British Society of Gastroenterology (BSG) Nurses Association and Research Committee review the current landscape.

Dec 7, 2023 | fg.bmj.com | R Mark Beattie |Paediatric Gastroenterology

Highlights from this issue Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Oct 10, 2023 | fg.bmj.com | R Mark Beattie |Paediatric Gastroenterology

Highlights from this issue Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Oct 6, 2023 | thelancet.com | Paediatric Gastroenterology |Feeding Disorders |Manoj Thakur |Nicholas Michael Croft

SummaryPrevious studies have demonstrated the tolerability and efficacy of multimatrix mesalamine in inducing and maintaining remission in adults with mild-to-moderate ulcerative colitis (UC). We evaluated the safety and efficacy of low-dose and high-dose once-daily multimatrix mesalamine in children and adolescents with mild-to-moderate UC or those in remission.